DE60128122D1 - Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen - Google Patents

Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen

Info

Publication number
DE60128122D1
DE60128122D1 DE60128122T DE60128122T DE60128122D1 DE 60128122 D1 DE60128122 D1 DE 60128122D1 DE 60128122 T DE60128122 T DE 60128122T DE 60128122 T DE60128122 T DE 60128122T DE 60128122 D1 DE60128122 D1 DE 60128122D1
Authority
DE
Germany
Prior art keywords
chromatinremodellating
iswi
atpases
similar
core programming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128122T
Other languages
English (en)
Inventor
Alan P Wolffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangamo Therapeutics Inc
Original Assignee
Sangamo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangamo Biosciences Inc filed Critical Sangamo Biosciences Inc
Application granted granted Critical
Publication of DE60128122D1 publication Critical patent/DE60128122D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60128122T 2000-09-28 2001-09-28 Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen Expired - Lifetime DE60128122D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23640900P 2000-09-28 2000-09-28
PCT/US2001/030384 WO2002026959A2 (en) 2000-09-28 2001-09-28 Nuclear reprogramming using iwsi and related chromatin remodeling atpases

Publications (1)

Publication Number Publication Date
DE60128122D1 true DE60128122D1 (de) 2007-06-06

Family

ID=22889379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128122T Expired - Lifetime DE60128122D1 (de) 2000-09-28 2001-09-28 Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen

Country Status (7)

Country Link
US (1) US7053264B2 (de)
EP (1) EP1328152B1 (de)
AT (1) ATE360361T1 (de)
AU (2) AU2001294851B2 (de)
CA (1) CA2423620A1 (de)
DE (1) DE60128122D1 (de)
WO (1) WO2002026959A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491534B2 (en) * 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
CN100448991C (zh) * 2000-12-22 2009-01-07 麒麟医药株式会社 用改变程序的供体染色质或供体细胞克隆哺乳动物的方法
US20020142397A1 (en) 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
CA2450652A1 (en) * 2001-06-14 2002-12-27 Infigen, Inc. Methods for cloning mammals using remodeling factors
EP1391503A1 (de) * 2002-08-12 2004-02-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Verfahren zur Umprogrammierung einer Zelle durch zytoplasmatichen Transfer
CA2539439C (en) 2003-09-19 2012-10-23 Sangamo Biosciences, Inc. Engineered zinc finger proteins for regulation of gene expression
WO2015070212A1 (en) 2013-11-11 2015-05-14 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
US9624498B2 (en) 2014-03-18 2017-04-18 Sangamo Biosciences, Inc. Methods and compositions for regulation of zinc finger protein expression
NZ743429A (en) 2015-12-18 2022-02-25 Sangamo Therapeutics Inc Targeted disruption of the mhc cell receptor
CN108778297B (zh) 2015-12-18 2024-02-09 桑格摩生物治疗股份有限公司 T细胞受体的靶向破坏
WO2018049009A2 (en) 2016-09-07 2018-03-15 Sangamo Therapeutics, Inc. Modulation of liver genes
US11512287B2 (en) 2017-06-16 2022-11-29 Sangamo Therapeutics, Inc. Targeted disruption of T cell and/or HLA receptors
US20220064596A1 (en) 2020-08-25 2022-03-03 Kite Pharma, Inc. T cells with improved functionality

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011197A (en) * 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
ATE517990T1 (de) * 2000-03-15 2011-08-15 Univ Georgia Effektive kernumprogrammierung in säugetieren
CA2407460C (en) * 2000-04-28 2013-06-25 Sangamo Biosciences, Inc. Targeted modification of chromatin structure

Also Published As

Publication number Publication date
US20020094968A1 (en) 2002-07-18
WO2002026959A2 (en) 2002-04-04
AU2001294851B2 (en) 2007-06-14
CA2423620A1 (en) 2002-04-04
EP1328152B1 (de) 2007-04-25
WO2002026959A9 (en) 2004-05-06
EP1328152A2 (de) 2003-07-23
US7053264B2 (en) 2006-05-30
AU9485101A (en) 2002-04-08
ATE360361T1 (de) 2007-05-15
WO2002026959A3 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
DE60128122D1 (de) Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen
DE60125342D1 (de) Humane pankreatische epitheliale stammzellen, verfahren zur ihrer isolierung und verwendungen davon
EP2266396A3 (de) Modulation von stammzellen mittels zinkfingerproteinen
EP1356035A4 (de) Verfahren zur klonierung von säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
DE60142553D1 (de) Isolierung und transplantation von retinalen stammzellen
DE69916807D1 (de) Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
IL152316A0 (en) Pharmaceutical compositions and kits for treating transplant rejection
DK1026950T3 (da) Behandling af skizofreni med ampakiner og neuroleptika
ES2194106T3 (es) .ompuestos de imidazol
DK1147089T3 (da) Phenylphenanthridiner med PDE-IV-inhiberende virkning
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
EE200000033A (et) Uudsed tetrasoolderivaadid
AU5340001A (en) A method to prevent graft rejection using tgf-beta to induce t suppressor cells
ATE426628T1 (de) Polyurethanderivatzusammensetzungen und verfahren zu ihrer herstellung
ATE397084T1 (de) Lentivirale verpackungskonstrukte
DE60019894D1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
DE60112742D1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
DE59712319D1 (de) Genfallen-konstrukt zur identifizierung und isolierung von genen
ATE431396T1 (de) Für hcv-infektion geeignete zusammensetzungen und verfahren
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
DE60228609D1 (de) Identifizierung und charakterisierung von genen
ATE473730T1 (de) Verwendung von 3-positions-cyclosporin-derivaten für haarwachstum
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
ES2194717T3 (es) Plantas transformadas con tiorredoxina.

Legal Events

Date Code Title Description
8332 No legal effect for de